CHRS - Coherus BioSciences - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

Coherus BioSciences's activity chart (see below) currently has 132 price targets and 115 ratings on display.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 11.93% with an average time for these price targets to be met of 59.09 days.

Most recent stock forecast was given by from MAXIM GROUP on 04-Sep-2025. First documented stock forecast 20-Jan-2016.

Best performing analysts who are covering CHRS - Coherus BioSciences:

Jason Mccarthy Ashwani Verma Ian Somaiya Yigal Nochomovitz Alethia Young Colleen Kusy

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Hold Since 04-Sep-2025

$4

$2.5 (166.67%)

1 years 1 months 1 days ago
(04-Sep-2025)

3/10 (30%)

$2.69 (205.34%)

181

Buy Since 07-May-2019

$7

$5.5 (366.67%)

$7

1 years 5 months 6 days ago
(29-Apr-2025)

0/5 (0%)

$6 (600.00%)

Buy Since 07-May-2019

1 years 5 months 6 days ago
(29-Apr-2025)

0/16 (0%)

$5.29 (309.36%)

Hold Since 24-Apr-2025

$1.05

$-0.45 (-30.00%)

1 years 5 months 11 days ago
(24-Apr-2025)

2/3 (66.67%)

$0.04 (3.96%)

9

Buy Since 23-Jan-2024

$6

$4.5 (300.00%)

1 years 10 months ago
(05-Dec-2024)

0/3 (0%)

$4.49 (297.35%)

Show more analysts

Please expand the browser size to see the chart

What is CHRS (Coherus BioSciences) average time for price targets to be met?

On average it took 59 days for the stock forecasts to be reached, with an average price target met ratio of 11.93%.

Which analyst most recently updated their price target on CHRS (Coherus BioSciences)?

Which analyst has the most public recommendations on CHRS (Coherus BioSciences)?

has 0 price targets and 0 ratings on CHRS

Which analyst is the currently most bullish on CHRS (Coherus BioSciences)?

Ian Somaiya with the highest potential upside of $36.84

Which analyst is the currently most reserved on CHRS (Coherus BioSciences)?

Ashwani Verma with the lowest potential downside of -$0.45
✖

To continue looking at which analysts cover the stock please register to the basic or advanced membership

To continue looking at analysts data please register to the advanced membership

What is AnaChart?